Get the Stockscreener App
86.31
2.14%
-1.6603
Proshares Ultra Nasdaq Biotechnology 2 X Shares stock is traded at $86.31, with a volume of 4,750.
It is down -2.14% in the last 24 hours and up +7.34% over the past month.
See More
Previous Close:
$87.97
Open:
$86.93
24h Volume:
4,750
Relative Volume:
0.45
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.05%
1M Performance:
+7.34%
6M Performance:
+30.02%
1Y Performance:
+111.42%
1-Day Range:
$85.97
$86.95
1-Week Range:
$81.22
$88.84
52-Week Range:
$39.47
$90.91
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
Name
Proshares Ultra Nasdaq Biotechnology 2 X Shares
Sector
Industry
Phone
-
Address
-
Compare BIB vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
86.37 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.95 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
701.40 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
704.63 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
279.50 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
639.98 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Latest News
Booking 60% Gains in Five Days and Featuring a Portfolio of New Option Recommendations - Stock Investor
Riding the Biotech Bull - Stock Investor
Biotech Breaks Out - Stock Investor
HCM Tactical Plus Fund's ProShares Ultra QQQ 2x Shares(QLD) Holding History - GuruFocus
HCM Tactical Plus Fund's ProShares Ultra S&P500 2x Shares(SSO) Holding History - GuruFocus
ProShares Ultra MidCap400 2X Shares (MVV) ETF HoldersInstitutional Ownership - GuruFocus
ProShares Ultra Real Estate 2X Shares (URE) ETF HoldersInstitutional Ownership - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 39.8% in March - MarketBeat
ProShares Ultra Nasdaq Biotechnology Declares Quarterly Dividend of $0.01 (NASDAQ:BIB) - MarketBeat
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving AverageWhat's Next? - marketbeat.com
ProShares UltraShort QQQ (NYSEARCA:QID) Share Price Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
ProShares UltraShort Bloomberg Natural Gas (NYSEARCA:KOLD) Shares Gap Up – Should You Buy? - Defense World
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Below 50 Day Moving AverageTime to Sell? - marketbeat.com
If the VIX Pushes Back Above 29 It’s A Nightmare For ETHT Investors - 24/7 Wall St.
US Stock ETF Tracker | A Handshake Deal! Wegovy officially launches on the Hims & Hers platform, with the 2x leveraged HIMS surging 80%; Cryptocurrency concepts strengthen as 2x leveraged CRCL and 2x leveraged BMNR rise nearly 20%. - 富途牛牛
BIB,PBE Earnings - Finviz
BIB,PBE Options - Finviz
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 18.4% in February - MarketBeat
Coelacanth Energy (CVE:CEI) Stock Price Down 1.2% – Should You Sell? - Defense World
Palumbo Wealth Management LLC Buys New Stake in ProShares Ultra Nasdaq Biotechnology $BIB - MarketBeat
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026 - TipRanks
Leveraged Oil & Energy ETFs Soar on Rising U.S.-Iran Tensions - Nasdaq
Direxion Daily AI and Big Data Bear 2X Shares (NYSEARCA:AIBD) Short Interest Update - Defense World
The 2x Leveraged SSO ETF Can Double Your Returns, Until Volatility Strikes - 24/7 Wall St.
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Down 16.3% in January - Defense World
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Increase in Short Interest - Defense World
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 27.9% in January - MarketBeat
US Stock ETF Tracker | Gold, silver, and equities plummet collectively as the VIX panic index surges; triple inverse Nasdaq ETF rises over 6%, double inverse silver ETF jumps more than 24%; announcement of a $1 billion convertible bond issuance, double in - 富途牛牛
Buy on the Dip Prospects: February 11 Edition - ETF Database
U.S. Stock ETF Tracker | Software stocks rally again, 2x Long SPOT ETF surges over 30%, 2x Long DDOG ETF rises more than 27%; Silver barely holds above $80, 2x Short Silver ETF jumps over 7%. - 富途牛牛
5 Small-cap Biotech ETFs to Watch - Investing News Network
U.S. Stock ETF Tracker | Precious metals stabilize and rebound, with the 2x Silver Leveraged ETF surging over 16% - 富途牛牛
A Leveraged Bet on the Broad Market or Big Tech: SPXL vs. QLD - The Motley Fool
Leverage Decay Is Destroying ETHU Faster Than Ethereum’s Actual Drop - 24/7 Wall St.
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Seagate earnings ignite storage sector, 2x Long WDC ETF surges nearly 25% - 富途牛牛
US Stock ETF Tracker | Gold records largest single-day gain, 2x Long Gold ETF rises over 7% - 富途牛牛
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above 50 Day Moving AverageHere's Why - MarketBeat
U.S. Stock ETF Tracker | Silver surpasses $100 for the first time, with the 2x Long Silver ETF up over 13% - 富途资讯
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
Buy on the Dip Prospects: January 21 Edition - ETF Database
Best ETFs for Day Trading – Updated Lists and Statistics - Trade That Swing
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Financials Data
There is no financial data for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.24%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):